{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T18:49:26Z","timestamp":1793818166942,"version":"4.6.1"},"reference-count":164,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,8,11]],"date-time":"2025-08-11T00:00:00Z","timestamp":1754870400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Metabolism Open"],"published-print":{"date-parts":[[2025,9]]},"DOI":"10.1016\/j.metop.2025.100385","type":"journal-article","created":{"date-parts":[[2025,8,11]],"date-time":"2025-08-11T23:28:26Z","timestamp":1754954906000},"page":"100385","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"special_numbering":"C","title":["Helicobacter pylori infection and association with chronic diseases: A focus on cardiovascular disease, MASLD, and type 2 diabetes"],"prefix":"10.1016","volume":"27","author":[{"given":"Navid","family":"Maleki","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alireza","family":"Mohammadzadeh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jalal","family":"Mardaneh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hossein","family":"Pazoki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0012-716X","authenticated-orcid":false,"given":"Elyas","family":"Nattagh-Eshtivani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.metop.2025.100385_bib1","first-page":"1","article-title":"Non-communicable diseases' risk factors in Iran; a review of the present status and action plans","author":"Azadnajafabad","year":"2021","journal-title":"J Diabetes Metab Disord"},{"issue":"9859","key":"10.1016\/j.metop.2025.100385_bib2","doi-asserted-by":"crossref","first-page":"2197","DOI":"10.1016\/S0140-6736(12)61689-4","article-title":"Disability-adjusted life years (DALYs) for 291 diseases and injuries in 21 regions, 1990-2010: a systematic analysis for the global burden of disease study 2010","volume":"380","author":"Murray","year":"2012","journal-title":"Lancet"},{"key":"10.1016\/j.metop.2025.100385_bib3","doi-asserted-by":"crossref","first-page":"296","DOI":"10.3389\/fpubh.2019.00296","article-title":"Non-communicable diseases and cognitive impairment: pathways and shared behavioral risk factors among older Chinese","volume":"7","author":"Yiengprugsawan","year":"2019","journal-title":"Front Public Health"},{"issue":"2","key":"10.1016\/j.metop.2025.100385_bib4","doi-asserted-by":"crossref","first-page":"302","DOI":"10.4103\/ijcm.ijcm_900_21","article-title":"Nonalcoholic fatty liver disease: role of medical colleges in its prevention and control","volume":"47","author":"Nath","year":"2022","journal-title":"Indian J Community Med"},{"issue":"10","key":"10.1016\/j.metop.2025.100385_bib5","doi-asserted-by":"crossref","DOI":"10.3390\/microorganisms10101907","article-title":"Bacterial infections among patients with chronic diseases at a tertiary care hospital in Saudi Arabia","volume":"10","author":"Bazaid","year":"2022","journal-title":"Microorganisms"},{"issue":"10","key":"10.1016\/j.metop.2025.100385_bib6","first-page":"1207","article-title":"Helicobacter pylori motility","volume":"2","author":"O'Toole","year":"2000","journal-title":"Microbes Infect"},{"issue":"Suppl 1","key":"10.1016\/j.metop.2025.100385_bib7","article-title":"Pathogenesis of Helicobacter pylori infection","volume":"22","author":"Camilo","year":"2017","journal-title":"Helicobacter"},{"issue":"5","key":"10.1016\/j.metop.2025.100385_bib8","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1053\/j.gastro.2016.01.028","article-title":"Association between Helicobacter pylori eradication and gastric cancer incidence: a systematic review and meta-analysis","volume":"150","author":"Lee","year":"2016","journal-title":"Gastroenterology"},{"issue":"3","key":"10.1016\/j.metop.2025.100385_bib9","first-page":"280","article-title":"Helicobacter pylori in Iran: a systematic review on the association of genotypes and gastroduodenal diseases","volume":"17","author":"Hosseini","year":"2012","journal-title":"J Res Med Sci"},{"issue":"8776","key":"10.1016\/j.metop.2025.100385_bib10","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1016\/0140-6736(91)92035-Z","article-title":"Helicobacter pylori-associated gastritis and primary B-cell gastric lymphoma","volume":"338","author":"Wotherspoon","year":"1991","journal-title":"Lancet"},{"issue":"11","key":"10.1016\/j.metop.2025.100385_bib11","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1056\/NEJMoa001999","article-title":"Helicobacter pylori infection and the development of gastric cancer","volume":"345","author":"Uemura","year":"2001","journal-title":"N Engl J Med"},{"key":"10.1016\/j.metop.2025.100385_bib12","doi-asserted-by":"crossref","first-page":"3","DOI":"10.3109\/00365529309098333","article-title":"Role of Helicobacter pylori in the pathogenesis of gastritis, peptic ulcer and gastric cancer","volume":"196","author":"Sipponen","year":"1993","journal-title":"Scand J Gastroenterol Suppl"},{"issue":"Suppl 1","key":"10.1016\/j.metop.2025.100385_bib13","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1046\/j.1365-2036.11.s1.5.x","article-title":"Helicobacter pylori and the risk and management of associated diseases: gastritis, ulcer disease, atrophic gastritis and gastric cancer","volume":"11","author":"Kuipers","year":"1997","journal-title":"Aliment Pharmacol Ther"},{"issue":"5","key":"10.1016\/j.metop.2025.100385_bib14","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1136\/hrt.71.5.437","article-title":"Relation of Helicobacter pylori infection and coronary heart disease","volume":"71","author":"Mendall","year":"1994","journal-title":"Br Heart J"},{"issue":"4","key":"10.1016\/j.metop.2025.100385_bib15","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/S0732-8893(02)00411-X","article-title":"Prevalence of Helicobacter pylori infection in asymptomatic subjects in Libya","volume":"43","author":"Bakka","year":"2002","journal-title":"Diagn Microbiol Infect Dis"},{"issue":"6","key":"10.1016\/j.metop.2025.100385_bib16","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1111\/j.1651-2227.2002.tb03293.x","article-title":"A longitudinal cohort study on the prevalence of Helicobacter pylori antibodies in Swedish children and adolescents","volume":"91","author":"Granquist","year":"2002","journal-title":"Acta Paediatr"},{"issue":"8","key":"10.1016\/j.metop.2025.100385_bib17","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1016\/S1286-4579(03)00112-6","article-title":"Helicobacter in the developing world","volume":"5","author":"Frenck","year":"2003","journal-title":"Microbes Infect"},{"issue":"4","key":"10.1016\/j.metop.2025.100385_bib18","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1111\/jdi.12991","article-title":"Helicobacter pylori eradication improves glycemic control in type 2 diabetes patients with asymptomatic active Helicobacter pylori infection","volume":"10","author":"Cheng","year":"2019","journal-title":"Journal of Diabetes Investigation"},{"issue":"7","key":"10.1016\/j.metop.2025.100385_bib19","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1507\/endocrj.EJ21-0591","article-title":"Association between Helicobacter pylori infection and the risk of type 2 diabetes mellitus based on a middle-aged and elderly Chinese population","volume":"69","author":"Zhou","year":"2022","journal-title":"Endocr J"},{"issue":"1","key":"10.1016\/j.metop.2025.100385_bib20","article-title":"A significant association between type 1 diabetes and Helicobacter pylori infection: a meta-analysis study","volume":"60","author":"Chua","year":"2024","journal-title":"Medicina (Kaunas)"},{"issue":"22","key":"10.1016\/j.metop.2025.100385_bib21","doi-asserted-by":"crossref","first-page":"2263","DOI":"10.1001\/jama.2015.5370","article-title":"Nonalcoholic fatty liver disease: a systematic review","volume":"313","author":"Rinella","year":"2015","journal-title":"JAMA"},{"issue":"3","key":"10.1016\/j.metop.2025.100385_bib22","doi-asserted-by":"crossref","DOI":"10.1002\/fsn3.70092","article-title":"Carotenoids improve obesity and fatty liver disease via gut microbiota: a narrative review","volume":"13","author":"Hashemi","year":"2025","journal-title":"Food Sci Nutr"},{"issue":"12","key":"10.1016\/j.metop.2025.100385_bib23","doi-asserted-by":"crossref","first-page":"1787","DOI":"10.1136\/gutjnl-2012-303816","article-title":"Intestinal microbiota determines development of non-alcoholic fatty liver disease in mice","volume":"62","author":"Le Roy","year":"2013","journal-title":"Gut"},{"issue":"7384","key":"10.1016\/j.metop.2025.100385_bib24","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1038\/nature10809","article-title":"Inflammasome-mediated dysbiosis regulates progression of NAFLD and obesity","volume":"482","author":"Henao-Mejia","year":"2012","journal-title":"Nature"},{"key":"10.1016\/j.metop.2025.100385_bib25","doi-asserted-by":"crossref","first-page":"619","DOI":"10.2147\/DMSO.S237866","article-title":"Relationship between Helicobacter pylori infection and nonalcoholic fatty liver disease (NAFLD) in a developing country: a cross-sectional study","volume":"13","author":"Abo-Amer","year":"2020","journal-title":"Diabetes Metab Syndr Obes"},{"key":"10.1016\/j.metop.2025.100385_bib26","article-title":"Bidirectional relationship between Helicobacter pylori infection and nonalcoholic fatty liver disease: insights from a comprehensive meta-analysis","volume":"11","author":"Zhang","year":"2024","journal-title":"Front Nutr"},{"key":"10.1016\/j.metop.2025.100385_bib27","doi-asserted-by":"crossref","first-page":"73","DOI":"10.3389\/fmicb.2018.00073","article-title":"Helicobacter pylori infection is not associated with non-alcoholic fatty liver disease: a cross-sectional study in China","volume":"9","author":"Fan","year":"2018","journal-title":"Front Microbiol"},{"issue":"1","key":"10.1016\/j.metop.2025.100385_bib28","first-page":"75","article-title":"Helicobacter pylori infection is not associated with nonalcoholic fatty liver disease: a two-year cohort study","volume":"43","author":"Zheng","year":"2025","journal-title":"Dig Dis"},{"issue":"4","key":"10.1016\/j.metop.2025.100385_bib29","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/j.imr.2016.05.005","article-title":"Helicobacter pylori and cardiovascular complications: a mechanism based review on role of Helicobacter pylori in cardiovascular diseases","volume":"5","author":"Jamkhande","year":"2016","journal-title":"Integr Med Res"},{"issue":"12","key":"10.1016\/j.metop.2025.100385_bib30","doi-asserted-by":"crossref","first-page":"5424","DOI":"10.1002\/ptr.7996","article-title":"The effect of propolis supplementation on cardiovascular risk factors in women with rheumatoid arthritis: a double\u2010blind, placebo, controlled randomized clinical trial","volume":"37","author":"Maddahi","year":"2023","journal-title":"Phytother Res"},{"issue":"4","key":"10.1016\/j.metop.2025.100385_bib31","doi-asserted-by":"crossref","first-page":"187","DOI":"10.4330\/wjc.v7.i4.187","article-title":"Helicobacter pylori vs coronary heart disease - searching for connections","volume":"7","author":"Chmiela","year":"2015","journal-title":"World J Cardiol"},{"issue":"9","key":"10.1016\/j.metop.2025.100385_bib32","doi-asserted-by":"crossref","DOI":"10.3390\/jcm11092282","article-title":"Increased risk to develop hypertension and carotid plaques in patients with long-lasting Helicobacter pylori gastritis","volume":"11","author":"Dore","year":"2022","journal-title":"J Clin Med"},{"key":"10.1016\/j.metop.2025.100385_bib33","doi-asserted-by":"crossref","first-page":"1533","DOI":"10.2147\/IJGM.S303071","article-title":"Relationship between Helicobacter pylori infection and arteriosclerosis","volume":"14","author":"Furuto","year":"2021","journal-title":"Int J Gen Med"},{"issue":"3","key":"10.1016\/j.metop.2025.100385_bib34","doi-asserted-by":"crossref","DOI":"10.1111\/hel.12967","article-title":"Helicobacter pylori infection and risk of cardiovascular disease","volume":"28","author":"Sun","year":"2023","journal-title":"Helicobacter"},{"issue":"18","key":"10.1016\/j.metop.2025.100385_bib35","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000025729","article-title":"Association between toll-like receptor gene polymorphisms and risk of Helicobacter pylori infection: a protocol for systematic review and meta-analysis","volume":"100","author":"Ma","year":"2021","journal-title":"Medicine (Baltim)"},{"issue":"4","key":"10.1016\/j.metop.2025.100385_bib36","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0176463","article-title":"Associations between cytokine gene polymorphisms and susceptibility to Helicobacter pylori infection and Helicobacter pylori related gastric cancer, peptic ulcer disease: a meta-analysis","volume":"12","author":"Ma","year":"2017","journal-title":"PLoS One"},{"issue":"2","key":"10.1016\/j.metop.2025.100385_bib37","doi-asserted-by":"crossref","first-page":"360","DOI":"10.14309\/ajg.0000000000002085","article-title":"Tailored treatment based on Helicobacter pylori genetic markers of resistance is associated with higher eradication success","volume":"118","author":"Cummings","year":"2023","journal-title":"Am J Gastroenterol"},{"issue":"6","key":"10.1016\/j.metop.2025.100385_bib38","doi-asserted-by":"crossref","DOI":"10.1111\/hel.13015","article-title":"Efficacy of genotypic susceptibility\u2010guided tailored therapy for Helicobacter pylori infection: a systematic review and single arm meta\u2010analysis","volume":"28","author":"Lin","year":"2023","journal-title":"Helicobacter"},{"issue":"6","key":"10.1016\/j.metop.2025.100385_bib39","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1161\/CIRCRESAHA.117.308903","article-title":"Reducing the global burden of cardiovascular disease, part 1: the epidemiology and risk factors","volume":"121","author":"Joseph","year":"2017","journal-title":"Circ Res"},{"issue":"8","key":"10.1016\/j.metop.2025.100385_bib40","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1161\/CIRCULATIONAHA.115.008721","article-title":"Resource effective strategies to prevent and treat cardiovascular disease","volume":"133","author":"Schwalm","year":"2016","journal-title":"Circulation"},{"issue":"29","key":"10.1016\/j.metop.2025.100385_bib41","doi-asserted-by":"crossref","first-page":"3204","DOI":"10.3748\/wjg.v24.i29.3204","article-title":"Helicobacter pylori and extragastric diseases: a review","volume":"24","author":"Gravina","year":"2018","journal-title":"World J Gastroenterol"},{"issue":"2","key":"10.1016\/j.metop.2025.100385_bib42","first-page":"222","article-title":"The relationship between Helicobacter pylori infection and myocardial infarction","volume":"2","author":"Azarkar","year":"2011","journal-title":"Caspian J Intern Med"},{"issue":"1","key":"10.1016\/j.metop.2025.100385_bib43","doi-asserted-by":"crossref","first-page":"45","DOI":"10.5114\/aoms.2015.50772","article-title":"Putative consequences of exposure to Helicobacter pylori infection in patients with coronary heart disease in terms of humoral immune response and inflammation","volume":"12","author":"Matusiak","year":"2016","journal-title":"Arch Med Sci"},{"issue":"3","key":"10.1016\/j.metop.2025.100385_bib44","doi-asserted-by":"crossref","first-page":"131","DOI":"10.5830\/CVJA-2011-016","article-title":"Prognostic role of Helicobacter pylori infection in acute coronary syndrome: a prospective cohort study","volume":"23","author":"Eskandarian","year":"2012","journal-title":"Cardiovasc J Afr"},{"issue":"8","key":"10.1016\/j.metop.2025.100385_bib45","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.1111\/jch.13928","article-title":"Helicobacter pylori infection and the prevalence of hypertension in Chinese adults: the dongfeng-tongji cohort","volume":"22","author":"Xiong","year":"2020","journal-title":"J Clin Hypertens"},{"issue":"6","key":"10.1016\/j.metop.2025.100385_bib46","doi-asserted-by":"crossref","DOI":"10.1177\/03000605231182545","article-title":"Association between Helicobacter pylori seropositivity and hypertension among adults in northern Sudan: a community-based case-control study","volume":"51","author":"Hassan","year":"2023","journal-title":"J Int Med Res"},{"issue":"8","key":"10.1016\/j.metop.2025.100385_bib47","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0221643","article-title":"Association between Helicobacter pylori infection and arterial stiffness: results from a large cross-sectional study","volume":"14","author":"Choi","year":"2019","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.metop.2025.100385_bib48","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1186\/s12941-025-00788-6","article-title":"Beyond the gut: a comprehensive meta-analysis on Helicobacter pylori infection and cardiovascular complications","volume":"24","author":"Yaslianifard","year":"2025","journal-title":"Ann Clin Microbiol Antimicrob"},{"issue":"50","key":"10.1016\/j.metop.2025.100385_bib49","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000018348","article-title":"Effect of Helicobacter pylori infection on the risk of acute coronary syndrome: a systematic review and meta-analysis","volume":"98","author":"Fang","year":"2019","journal-title":"Medicine (Baltim)"},{"issue":"23","key":"10.1016\/j.metop.2025.100385_bib50","doi-asserted-by":"crossref","first-page":"2539","DOI":"10.1016\/j.carres.2003.07.008","article-title":"Immunology of bacterial polysaccharide antigens","volume":"338","author":"Weintraub","year":"2003","journal-title":"Carbohydr Res"},{"issue":"43","key":"10.1016\/j.metop.2025.100385_bib51","doi-asserted-by":"crossref","first-page":"6745","DOI":"10.3748\/wjg.v11.i43.6745","article-title":"Soluble adhesion molecules ICAM-1, VCAM-1, P-selectin in children with Helicobacter pylori infection","volume":"11","author":"Maciorkowska","year":"2005","journal-title":"World J Gastroenterol"},{"issue":"3","key":"10.1016\/j.metop.2025.100385_bib52","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1111\/j.1365-2036.2004.02074.x","article-title":"Increased thrombin generation and circulating levels of tumour necrosis factor-alpha in patients with chronic helicobacter pylori-positive gastritis","volume":"20","author":"Consolazio","year":"2004","journal-title":"Aliment Pharmacol Ther"},{"issue":"2","key":"10.1016\/j.metop.2025.100385_bib53","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1016\/S0021-9150(99)00210-5","article-title":"Chronic infection with Helicobacter pylori does not provoke major systemic inflammation in healthy adults: results from a large population-based study","volume":"147","author":"Brenner","year":"1999","journal-title":"Atherosclerosis"},{"issue":"4","key":"10.1016\/j.metop.2025.100385_bib54","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1007\/s10787-014-0206-z","article-title":"Modulation of gastric mucosal inflammatory responses to Helicobacter pylori via ghrelin-induced protein kinase C\u03b4 tyrosine phosphorylation","volume":"22","author":"Slomiany","year":"2014","journal-title":"Inflammopharmacology"},{"issue":"1","key":"10.1016\/j.metop.2025.100385_bib55","doi-asserted-by":"crossref","DOI":"10.13172\/2052-787X-1-1-412","article-title":"Role of epidermal growth factor receptor transactivation in the amplification of helicobacter pylori-elicited induction in gastric mucosal expression of cyclooxygenase-2 and inducible nitric oxide synthase","volume":"1","author":"Slomiany","year":"2013","journal-title":"OA Inflamm"},{"issue":"1","key":"10.1016\/j.metop.2025.100385_bib56","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1186\/s43044-021-00185-2","article-title":"Association of Helicobacter pylori infection with coronary artery disease: is it an independent risk factor?","volume":"73","author":"Riad","year":"2021","journal-title":"Egypt Heart J"},{"key":"10.1016\/j.metop.2025.100385_bib57","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1186\/1741-7015-11-117","article-title":"Immunity, atherosclerosis and cardiovascular disease","volume":"11","author":"Frosteg\u00e5rd","year":"2013","journal-title":"BMC Med"},{"issue":"2","key":"10.1016\/j.metop.2025.100385_bib58","first-page":"105","article-title":"Assessment of the relationship between serum fibrinogen level and chronic Helicobacter pylori infection in patients with or without","volume":"21","author":"Faghihi","year":"2007","journal-title":"Med J Islam Repub Iran"},{"key":"10.1016\/j.metop.2025.100385_bib59","doi-asserted-by":"crossref","DOI":"10.1155\/2010\/685903","article-title":"Helicobacter pylori eradication lowers serum asymmetric dimethylarginine levels","volume":"2010","author":"Aydemir","year":"2010","journal-title":"Mediators Inflamm"},{"issue":"Suppl 1","key":"10.1016\/j.metop.2025.100385_bib60","first-page":"239","article-title":"Attempts to detect Helicobacter pylori in atherosclerotic plaques","volume":"49","author":"Sulewska","year":"2004","journal-title":"Rocz Akad Med Bialymst"},{"issue":"6","key":"10.1016\/j.metop.2025.100385_bib61","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1111\/j.1523-5378.2003.00180.x","article-title":"Eradication of Helicobacter pylori infection improves blood pressure values in patients affected by hypertension","volume":"8","author":"Migneco","year":"2003","journal-title":"Helicobacter"},{"issue":"1","key":"10.1016\/j.metop.2025.100385_bib62","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1186\/s12879-022-07718-3","article-title":"Relationship between active Helicobacter pylori infection and risk factors of cardiovascular diseases, a cross-sectional hospital-based study in a sub-saharan setting","volume":"22","author":"Tali","year":"2022","journal-title":"BMC Infect Dis"},{"key":"10.1016\/j.metop.2025.100385_bib63","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.atherosclerosis.2019.10.005","article-title":"Helicobacter pylori infection selectively increases the risk for carotid atherosclerosis in young males","volume":"291","author":"Zhang","year":"2019","journal-title":"Atherosclerosis"},{"issue":"1","key":"10.1016\/j.metop.2025.100385_bib64","article-title":"Association between Helicobacter pylori eradication and the risk of coronary heart diseases","volume":"13","author":"Wang","year":"2018","journal-title":"PLoS One"},{"issue":"2","key":"10.1016\/j.metop.2025.100385_bib65","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1038\/s41371-017-0028-8","article-title":"Helicobacter pylori infection and prevalence of high blood pressure among Chinese adults","volume":"32","author":"Wan","year":"2018","journal-title":"J Hum Hypertens"},{"key":"10.1016\/j.metop.2025.100385_bib66","doi-asserted-by":"crossref","first-page":"813","DOI":"10.2147\/CIA.S72724","article-title":"Helicobacter pylori infection in Chinese patients with atrial fibrillation","volume":"10","author":"Wang","year":"2015","journal-title":"Clin Interv Aging"},{"issue":"3","key":"10.1016\/j.metop.2025.100385_bib67","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1136\/jclinpath-2013-201743","article-title":"Cross-sectional study: caga-positive Helicobacter pylori infection, acute coronary artery disease and systemic levels of B-type natriuretic peptide","volume":"67","author":"Figura","year":"2014","journal-title":"J Clin Pathol"},{"issue":"4","key":"10.1016\/j.metop.2025.100385_bib68","first-page":"138","article-title":"Association of Helicobacter pylori infection with severity of coronary heart disease","volume":"7","author":"Rogha","year":"2012","journal-title":"ARYA Atheroscler"},{"issue":"5","key":"10.1016\/j.metop.2025.100385_bib69","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1007\/s00415-010-5824-9","article-title":"Influence of CagA-positive Helicobacter pylori strains on atherosclerotic carotid disease","volume":"258","author":"Ro\u017eankovi\u0107","year":"2011","journal-title":"J Neurol"},{"issue":"3","key":"10.1016\/j.metop.2025.100385_bib70","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1080\/00365540701642153","article-title":"Abdominal aortic aneurysm and infection with CagA positive strains of Helicobacter pylori","volume":"40","author":"Nyberg","year":"2008","journal-title":"Scand J Infect Dis"},{"issue":"3","key":"10.1016\/j.metop.2025.100385_bib71","doi-asserted-by":"crossref","first-page":"171","DOI":"10.5152\/tjg.2022.21467","article-title":"Helicobacter pylori infection and non-alcoholic fatty liver disease: a systematic review and meta-analysis","volume":"33","author":"Heydari","year":"2022","journal-title":"Turk J Gastroenterol"},{"issue":"33","key":"10.1016\/j.metop.2025.100385_bib72","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000034605","article-title":"Helicobacter pylori infection increases the risk of nonalcoholic fatty liver disease: possible relationship from an updated meta-analysis","volume":"102","author":"Liu","year":"2023","journal-title":"Medicine"},{"issue":"4","key":"10.1016\/j.metop.2025.100385_bib73","doi-asserted-by":"crossref","first-page":"564","DOI":"10.4254\/wjh.v15.i4.564","article-title":"Peptic ulcer disease in non-alcoholic fatty liver disease hospitalizations: a new challenge on the horizon in the United States","volume":"15","author":"Dahiya","year":"2023","journal-title":"World J Hepatol"},{"issue":"11","key":"10.1016\/j.metop.2025.100385_bib74","doi-asserted-by":"crossref","first-page":"2303","DOI":"10.7150\/ijms.50748","article-title":"H. pylori is related to nafld but only in female: a cross-sectional study","volume":"18","author":"Wang","year":"2021","journal-title":"Int J Med Sci"},{"issue":"7","key":"10.1016\/j.metop.2025.100385_bib75","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.1111\/liv.15925","article-title":"Relationship between Helicobacter pylori infection and risk of metabolic dysfunction-associated steatotic liver disease: an updated meta-analysis","volume":"44","author":"Mantovani","year":"2024","journal-title":"Liver Int"},{"issue":"4","key":"10.1016\/j.metop.2025.100385_bib76","doi-asserted-by":"crossref","DOI":"10.3390\/jcm14041073","article-title":"Persistently active Helicobacter pylori infection is associated with the development of metabolic dysfunction-associated steatotic liver disease","volume":"14","author":"Kim","year":"2025","journal-title":"J Clin Med"},{"issue":"2","key":"10.1016\/j.metop.2025.100385_bib77","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1002\/hep.26672","article-title":"Nonalcoholic fatty liver disease, hepatic insulin resistance, and type 2 diabetes","volume":"59","author":"Birkenfeld","year":"2014","journal-title":"Hepatology"},{"issue":"1","key":"10.1016\/j.metop.2025.100385_bib78","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.metabol.2012.06.007","article-title":"Helicobacter pylori infection in patients with nonalcoholic fatty liver disease","volume":"62","author":"Polyzos","year":"2013","journal-title":"Metabolism"},{"key":"10.1016\/j.metop.2025.100385_bib79","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1186\/s13104-016-2071-x","article-title":"Subclinical inflammation in relation to insulin resistance in prediabetic subjects with nonalcoholic fatty liver disease","volume":"9","author":"Hossain","year":"2016","journal-title":"BMC Res Notes"},{"issue":"8","key":"10.1016\/j.metop.2025.100385_bib80","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1080\/21505594.2015.1043505","article-title":"Helicobacter pylori neutrophil-activating protein induces release of histamine and interleukin-6 through G protein-mediated MAPKs and PI3K\/Akt pathways in HMC-1 cells","volume":"6","author":"Tsai","year":"2015","journal-title":"Virulence"},{"issue":"5249","key":"10.1016\/j.metop.2025.100385_bib81","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1126\/science.271.5249.665","article-title":"IRS-1-mediated inhibition of insulin receptor tyrosine kinase activity in TNF-alpha- and obesity-induced insulin resistance","volume":"271","author":"Hotamisligil","year":"1996","journal-title":"Science"},{"issue":"5","key":"10.1016\/j.metop.2025.100385_bib82","doi-asserted-by":"crossref","first-page":"8591","DOI":"10.3390\/ijms15058591","article-title":"Evolving concepts in the pathogenesis of NASH: beyond steatosis and inflammation","volume":"15","author":"Peverill","year":"2014","journal-title":"Int J Mol Sci"},{"issue":"7","key":"10.1016\/j.metop.2025.100385_bib83","doi-asserted-by":"crossref","first-page":"1793","DOI":"10.1172\/JCI29069","article-title":"Inflammation and insulin resistance","volume":"116","author":"Shoelson","year":"2006","journal-title":"J Clin Investig"},{"key":"10.1016\/j.metop.2025.100385_bib84","doi-asserted-by":"crossref","DOI":"10.1155\/2015\/181643","article-title":"Molecular events linking oxidative stress and inflammation to insulin resistance and \u03b2-Cell dysfunction","volume":"2015","author":"Keane","year":"2015","journal-title":"Oxid Med Cell Longev"},{"issue":"11","key":"10.1016\/j.metop.2025.100385_bib85","first-page":"1583","article-title":"High sensitive CRP and pentraxine 3 as noninvasive biomarkers of nonalcoholic fatty liver disease","volume":"18","author":"Maleki","year":"2014","journal-title":"Eur Rev Med Pharmacol Sci"},{"issue":"5","key":"10.1016\/j.metop.2025.100385_bib86","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1016\/j.febslet.2010.01.044","article-title":"NOX3-derived reactive oxygen species promote TNF-alpha-induced reductions in hepatocyte glycogen levels via a JNK pathway","volume":"584","author":"Li","year":"2010","journal-title":"FEBS Lett"},{"issue":"1","key":"10.1016\/j.metop.2025.100385_bib87","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1152\/physrev.00013.2007","article-title":"Hepatic stellate cells: protean, multifunctional, and enigmatic cells of the liver","volume":"88","author":"Friedman","year":"2008","journal-title":"Physiol Rev"},{"issue":"2","key":"10.1016\/j.metop.2025.100385_bib88","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1053\/jhep.2002.34738","article-title":"Serum leptin in NASH correlates with hepatic steatosis but not fibrosis: a manifestation of lipotoxicity?","volume":"36","author":"Chitturi","year":"2002","journal-title":"Hepatology"},{"issue":"3","key":"10.1016\/j.metop.2025.100385_bib89","first-page":"158","article-title":"Association between Helicobacter pylori and serum leptin in Iranian dyspeptic patients","volume":"5","author":"Hemmasi","year":"2013","journal-title":"Middle East J Dig Dis"},{"issue":"5","key":"10.1016\/j.metop.2025.100385_bib90","doi-asserted-by":"crossref","first-page":"695","DOI":"10.3748\/wjg.v11.i5.695","article-title":"Enhanced production of leptin in gastric fundic mucosa with Helicobacter pylori infection","volume":"11","author":"Nishi","year":"2005","journal-title":"World J Gastroenterol"},{"issue":"6","key":"10.1016\/j.metop.2025.100385_bib91","doi-asserted-by":"crossref","first-page":"1655","DOI":"10.1016\/S0002-9440(10)62476-5","article-title":"The roles of leptin and adiponectin: a novel paradigm in adipocytokine regulation of liver fibrosis and stellate cell biology","volume":"166","author":"Ding","year":"2005","journal-title":"Am J Pathol"},{"issue":"8","key":"10.1016\/j.metop.2025.100385_bib92","doi-asserted-by":"crossref","first-page":"1206","DOI":"10.1096\/fj.05-4635fje","article-title":"Leptin down-regulates insulin action through phosphorylation of serine-318 in insulin receptor substrate 1","volume":"20","author":"Hennige","year":"2006","journal-title":"Faseb j"},{"key":"10.1016\/j.metop.2025.100385_bib93","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1186\/1476-511X-9-42","article-title":"The role of hepatic fat accumulation in pathogenesis of non-alcoholic fatty liver disease (NAFLD)","volume":"9","author":"Liu","year":"2010","journal-title":"Lipids Health Dis"},{"issue":"6","key":"10.1016\/j.metop.2025.100385_bib94","doi-asserted-by":"crossref","first-page":"E1709","DOI":"10.1152\/ajpendo.00444.2007","article-title":"Effect of liver fat on insulin clearance","volume":"293","author":"Kotronen","year":"2007","journal-title":"Am J Physiol Endocrinol Metab"},{"issue":"2","key":"10.1016\/j.metop.2025.100385_bib95","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.bbabio.2005.07.006","article-title":"Distinct characteristics of Ca(2+)-induced depolarization of isolated brain and liver mitochondria","volume":"1709","author":"Vergun","year":"2005","journal-title":"Biochim Biophys Acta"},{"issue":"3","key":"10.1016\/j.metop.2025.100385_bib96","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1097\/SMJ.0b013e3181cf373f","article-title":"Effect of Helicobacter pylori eradication on insulin resistance, serum lipids and low-grade inflammation","volume":"103","author":"Gen","year":"2010","journal-title":"South Med J"},{"issue":"3","key":"10.1016\/j.metop.2025.100385_bib97","doi-asserted-by":"crossref","DOI":"10.1111\/hel.12588","article-title":"Helicobacter pylori infection and nonalcoholic fatty liver disease: time for large clinical trials evaluating eradication therapy","volume":"24","author":"Polyzos","year":"2019","journal-title":"Helicobacter"},{"issue":"3","key":"10.1016\/j.metop.2025.100385_bib98","doi-asserted-by":"crossref","DOI":"10.1111\/hel.12576","article-title":"Association between Helicobacter pylori infection and nonalcoholic fatty liver disease: a systematic review and meta-analysis of observational studies","volume":"24","author":"Zhou","year":"2019","journal-title":"Helicobacter"},{"issue":"1","key":"10.1016\/j.metop.2025.100385_bib99","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1002\/hep.26319","article-title":"Intestinal microbiota in patients with nonalcoholic fatty liver disease","volume":"58","author":"Mouzaki","year":"2013","journal-title":"Hepatology"},{"key":"10.1016\/j.metop.2025.100385_bib100","doi-asserted-by":"crossref","first-page":"8096","DOI":"10.1038\/srep08096","article-title":"Dysbiosis gut microbiota associated with inflammation and impaired mucosal immune function in intestine of humans with non-alcoholic fatty liver disease","volume":"5","author":"Jiang","year":"2015","journal-title":"Sci Rep"},{"issue":"3","key":"10.1016\/j.metop.2025.100385_bib101","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1002\/hep.28356","article-title":"The severity of nonalcoholic fatty liver disease is associated with gut dysbiosis and shift in the metabolic function of the gut microbiota","volume":"63","author":"Boursier","year":"2016","journal-title":"Hepatology"},{"issue":"9","key":"10.1016\/j.metop.2025.100385_bib102","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1007\/s00535-015-1039-2","article-title":"Helicobacter pylori infection might have a potential role in hepatocyte ballooning in nonalcoholic fatty liver disease","volume":"50","author":"Sumida","year":"2015","journal-title":"J Gastroenterol"},{"issue":"Suppl 1","key":"10.1016\/j.metop.2025.100385_bib103","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1159\/000051918","article-title":"Helicobacter pylori infection increases mucosal permeability of the stomach and intestine","volume":"63","author":"Fukuda","year":"2001","journal-title":"Digestion"},{"issue":"12","key":"10.1016\/j.metop.2025.100385_bib104","doi-asserted-by":"crossref","DOI":"10.5812\/hepatmon.14679","article-title":"The effect of Helicobacter pylori eradication on liver fat content in subjects with non-alcoholic fatty liver disease: a randomized open-label clinical trial","volume":"13","author":"Jamali","year":"2013","journal-title":"Hepat Mon"},{"key":"10.1016\/j.metop.2025.100385_bib105","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1186\/s12876-015-0247-9","article-title":"Helicobacter pylori infection is not associated with fatty liver disease including non-alcoholic fatty liver disease: a large-scale cross-sectional study in Japan","volume":"15","author":"Okushin","year":"2015","journal-title":"BMC Gastroenterol"},{"issue":"9","key":"10.1016\/j.metop.2025.100385_bib106","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1007\/s00535-015-1039-2","article-title":"Helicobacter pylori infection might have a potential role in hepatocyte ballooning in nonalcoholic fatty liver disease","volume":"50","author":"Sumida","year":"2015","journal-title":"J Gastroenterol"},{"issue":"8","key":"10.1016\/j.metop.2025.100385_bib107","doi-asserted-by":"crossref","first-page":"2592","DOI":"10.3748\/wjg.v22.i8.2592","article-title":"Helicobacter pylori infection is not associated with nonalcoholic fatty liver disease","volume":"22","author":"Baeg","year":"2016","journal-title":"World J Gastroenterol"},{"issue":"8","key":"10.1016\/j.metop.2025.100385_bib108","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0202325","article-title":"Association between cagA negative Helicobacter pylori status and nonalcoholic fatty liver disease among adults in the United States","volume":"13","author":"Kang","year":"2018","journal-title":"PLoS One"},{"issue":"46","key":"10.1016\/j.metop.2025.100385_bib109","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000013271","article-title":"The associations among Helicobacter pylori infection, white blood cell count and nonalcoholic fatty liver disease in a large Chinese population","volume":"97","author":"Yu","year":"2018","journal-title":"Medicine (Baltim)"},{"issue":"JAN","key":"10.1016\/j.metop.2025.100385_bib110","article-title":"Helicobacter pylori infection is not associated with non-alcoholic fatty liver disease: a cross-sectional study in China","volume":"9","author":"Fan","year":"2018","journal-title":"Front Microbiol"},{"issue":"7","key":"10.1016\/j.metop.2025.100385_bib111","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1097\/MEG.0000000000001601","article-title":"Helicobacter pylori infection May increase the severity of nonalcoholic fatty liver disease via promoting liver function damage, glycometabolism, lipid metabolism, inflammatory reaction and metabolic syndrome","volume":"32","author":"Chen","year":"2020","journal-title":"Eur J Gastroenterol Hepatol"},{"issue":"2","key":"10.1016\/j.metop.2025.100385_bib112","doi-asserted-by":"crossref","first-page":"168","DOI":"10.25122\/jml-2019-0012","article-title":"Relevance between Helicobacter pylori infection and non-alcoholic fatty liver disease in birjand, Iran","volume":"12","author":"Mohammadifard","year":"2019","journal-title":"J Med Life"},{"key":"10.1016\/j.metop.2025.100385_bib113","doi-asserted-by":"crossref","first-page":"619","DOI":"10.2147\/DMSO.S237866","article-title":"Relationship between Helicobacter pylori infection and nonalcoholic fatty liver disease (nafld) in a developing country: a cross-sectional study","volume":"13","author":"Abo-Amer","year":"2020","journal-title":"Diabetes, Metabolic Syndrome and Obesity"},{"issue":"6","key":"10.1016\/j.metop.2025.100385_bib114","doi-asserted-by":"crossref","DOI":"10.1111\/hel.12756","article-title":"Associations between Helicobacter pylori with nonalcoholic fatty liver disease and other metabolic conditions in Guatemala","volume":"25","author":"Alvarez","year":"2020","journal-title":"Helicobacter"},{"key":"10.1016\/j.metop.2025.100385_bib115","doi-asserted-by":"crossref","DOI":"10.1177\/20503121211025421","article-title":"Frequency and risk factors of non-alcoholic fatty liver disease in helicobacter pylori-infected dyspeptic patients: a cross-sectional study","volume":"9","author":"Siddiqui","year":"2021","journal-title":"SAGE Open Med"},{"issue":"12 December","key":"10.1016\/j.metop.2025.100385_bib116","article-title":"Research article the association between Helicobacter pylori with nonalcoholic fatty liver disease assessed by controlled attenuation parameter and other metabolic factors","volume":"16","author":"Han","year":"2021","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.metop.2025.100385_bib117","doi-asserted-by":"crossref","first-page":"20","DOI":"10.4103\/jrms.JRMS_236_20","article-title":"Nigella sativa in controlling type 2 diabetes, cardiovascular, and rheumatoid arthritis diseases: molecular aspects","volume":"26","author":"Hadi","year":"2021","journal-title":"J Res Med Sci"},{"issue":"27","key":"10.1016\/j.metop.2025.100385_bib118","article-title":"Clinical therapeutic effects of eradication of Helicobacter pylori in treating patients with type 2 diabetes mellitus A protocol for systematic review and meta-analysis","volume":"100","author":"Shi","year":"2021","journal-title":"Medicine (United States)"},{"key":"10.1016\/j.metop.2025.100385_bib119","doi-asserted-by":"crossref","DOI":"10.1155\/2014\/391250","article-title":"Helicobacter pylori infection and insulin resistance in diabetic and nondiabetic population","volume":"2014","author":"Vafaeimanesh","year":"2014","journal-title":"Sci World J"},{"issue":"25","key":"10.1016\/j.metop.2025.100385_bib120","first-page":"1325","article-title":"[the significance of Campylobacter pylori infection in gastroenterologic and diabetic practice]","volume":"130","author":"Simon","year":"1989","journal-title":"Orv Hetil"},{"issue":"8","key":"10.1016\/j.metop.2025.100385_bib121","doi-asserted-by":"crossref","DOI":"10.3390\/nu11081874","article-title":"Lack of association between past Helicobacter pylori infection and diabetes: a two-cohort study","volume":"11","author":"Pyo","year":"2019","journal-title":"Nutrients"},{"issue":"1","key":"10.1016\/j.metop.2025.100385_bib122","doi-asserted-by":"crossref","first-page":"15","DOI":"10.4093\/dmj.2021.0280","article-title":"Insulin resistance: from mechanisms to therapeutic strategies","volume":"46","author":"Lee","year":"2022","journal-title":"Diabetes Metab J"},{"issue":"2","key":"10.1016\/j.metop.2025.100385_bib123","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1111\/j.1523-5378.2011.00822.x","article-title":"The association between Helicobacter pylori infection and insulin resistance: a systematic review","volume":"16","author":"Polyzos","year":"2011","journal-title":"Helicobacter"},{"issue":"5","key":"10.1016\/j.metop.2025.100385_bib124","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1111\/j.1523-5378.2009.00705.x","article-title":"Helicobacter pylori infection significantly increases insulin resistance in the asymptomatic Japanese population","volume":"14","author":"Gunji","year":"2009","journal-title":"Helicobacter"},{"issue":"4","key":"10.1016\/j.metop.2025.100385_bib125","first-page":"508","article-title":"Helicobacter pylori eradication has no effect on metabolic and inflammatory parameters","volume":"97","author":"Park","year":"2005","journal-title":"J Natl Med Assoc"},{"issue":"7","key":"10.1016\/j.metop.2025.100385_bib126","doi-asserted-by":"crossref","first-page":"1894","DOI":"10.1097\/01.ASN.0000019900.87535.43","article-title":"Insulin resistance as an independent predictor of cardiovascular mortality in patients with end-stage renal disease","volume":"13","author":"Shinohara","year":"2002","journal-title":"J Am Soc Nephrol"},{"issue":"8825","key":"10.1016\/j.metop.2025.100385_bib127","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1016\/0140-6736(92)92816-X","article-title":"Effect of Helicobacter pylori on gastric somatostatin in duodenal ulcer disease","volume":"340","author":"Moss","year":"1992","journal-title":"Lancet"},{"issue":"11","key":"10.1016\/j.metop.2025.100385_bib128","doi-asserted-by":"crossref","first-page":"2090","DOI":"10.1007\/s10620-005-3012-z","article-title":"The effect of Helicobacter pylori on insulin resistance","volume":"50","author":"Aydemir","year":"2005","journal-title":"Dig Dis Sci"},{"issue":"6","key":"10.1016\/j.metop.2025.100385_bib129","doi-asserted-by":"crossref","first-page":"2350","DOI":"10.1210\/jc.2007-2057","article-title":"Leptin and ghrelin in relation to Helicobacter pylori status in adult males","volume":"93","author":"Roper","year":"2008","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.metop.2025.100385_bib130","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1186\/1471-230X-11-37","article-title":"The effect of H. pylori eradication on meal-associated changes in plasma ghrelin and leptin","volume":"11","author":"Francois","year":"2011","journal-title":"BMC Gastroenterol"},{"issue":"5","key":"10.1016\/j.metop.2025.100385_bib131","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1172\/JCI118891","article-title":"Identification of targets of leptin action in rat hypothalamus","volume":"98","author":"Schwartz","year":"1996","journal-title":"J Clin Investig"},{"issue":"11","key":"10.1016\/j.metop.2025.100385_bib132","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1301\/nr.2003.nov.391-393","article-title":"A critical interaction: Leptin and ghrelin","volume":"61","author":"Williams","year":"2003","journal-title":"Nutr Rev"},{"issue":"25","key":"10.1016\/j.metop.2025.100385_bib133","first-page":"3183","article-title":"Ghrelin's second life: from appetite stimulator to glucose regulator","volume":"18","author":"Verhulst","year":"2012","journal-title":"World J Gastroenterol"},{"issue":"6806","key":"10.1016\/j.metop.2025.100385_bib134","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1038\/35038090","article-title":"Ghrelin induces adiposity in rodents","volume":"407","author":"Tsch\u00f6p","year":"2000","journal-title":"Nature"},{"issue":"5","key":"10.1016\/j.metop.2025.100385_bib135","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1136\/gut.52.5.637","article-title":"Plasma ghrelin following cure of Helicobacter pylori","volume":"52","author":"Nwokolo","year":"2003","journal-title":"Gut"},{"issue":"3","key":"10.1016\/j.metop.2025.100385_bib136","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1007\/s005920200027","article-title":"Insulin-resistant patients with type 2 diabetes mellitus have higher serum leptin levels independently of body fat mass","volume":"39","author":"Fischer","year":"2002","journal-title":"Acta Diabetol"},{"issue":"1","key":"10.1016\/j.metop.2025.100385_bib137","first-page":"45","article-title":"Helicobacter pylori infection and inflammation: implication for the pathophysiology of diabetes and coronary heart disease in Asian Indians","volume":"1","author":"Rahman","year":"2009","journal-title":"J Life Sci"},{"issue":"1","key":"10.1016\/j.metop.2025.100385_bib138","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/S1658-3612(09)70082-4","article-title":"Helicobacter pylori infection and vascular complications in patients with type 2 diabetes mellitus","volume":"4","author":"El Hadidy","year":"2009","journal-title":"Journal of Taibah University Medical Sciences"},{"issue":"8","key":"10.1016\/j.metop.2025.100385_bib139","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1016\/j.jacc.2005.01.019","article-title":"Association of Helicobacter pylori infection with systemic inflammation and endothelial dysfunction in healthy Male subjects","volume":"45","author":"Oshima","year":"2005","journal-title":"J Am Coll Cardiol"},{"issue":"2","key":"10.1016\/j.metop.2025.100385_bib140","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.jstrokecerebrovasdis.2007.10.006","article-title":"Vascular risks and complications in diabetes mellitus: the role of Helicobacter pylori infection","volume":"17","author":"Hamed","year":"2008","journal-title":"J Stroke Cerebrovasc Dis"},{"issue":"5","key":"10.1016\/j.metop.2025.100385_bib141","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1172\/JCI25102","article-title":"Inflammation, stress, and diabetes","volume":"115","author":"Wellen","year":"2005","journal-title":"J Clin Investig"},{"issue":"8","key":"10.1016\/j.metop.2025.100385_bib142","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1007\/s00125-004-1472-x","article-title":"C-reactive protein and the development of the metabolic syndrome and diabetes in middle-aged men","volume":"47","author":"Laaksonen","year":"2004","journal-title":"Diabetologia"},{"issue":"5","key":"10.1016\/j.metop.2025.100385_bib143","doi-asserted-by":"crossref","first-page":"1596","DOI":"10.2337\/diabetes.51.5.1596","article-title":"C-reactive protein is an independent predictor of risk for the development of diabetes in the west of Scotland coronary prevention study","volume":"51","author":"Freeman","year":"2002","journal-title":"Diabetes"},{"issue":"10","key":"10.1016\/j.metop.2025.100385_bib144","doi-asserted-by":"crossref","first-page":"2384","DOI":"10.2337\/diabetes.50.10.2384","article-title":"The relation of markers of inflammation to the development of glucose disorders in the elderly: the cardiovascular health study","volume":"50","author":"Barzilay","year":"2001","journal-title":"Diabetes"},{"issue":"3","key":"10.1016\/j.metop.2025.100385_bib145","doi-asserted-by":"crossref","first-page":"812","DOI":"10.2337\/diabetes.52.3.812","article-title":"Inflammatory cytokines and the risk to develop type 2 diabetes: results of the prospective population-based european prospective investigation into cancer and nutrition (EPIC)-potsdam study","volume":"52","author":"Spranger","year":"2003","journal-title":"Diabetes"},{"issue":"5091","key":"10.1016\/j.metop.2025.100385_bib146","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1126\/science.7678183","article-title":"Adipose expression of tumor necrosis factor-alpha: direct role in obesity-linked insulin resistance","volume":"259","author":"Hotamisligil","year":"1993","journal-title":"Science"},{"issue":"2","key":"10.1016\/j.metop.2025.100385_bib147","doi-asserted-by":"crossref","first-page":"170","DOI":"10.4239\/wjd.v15.i2.170","article-title":"Identification of hub genes associated with Helicobacter pylori infection and type 2 diabetes mellitus: a pilot bioinformatics study","volume":"15","author":"Chen","year":"2024","journal-title":"World J Diabetes"},{"issue":"1","key":"10.1016\/j.metop.2025.100385_bib148","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1186\/s12902-024-01694-2","article-title":"Association between Helicobacter pylori infection and type 2 diabetes mellitus: a retrospective cohort study and bioinformatics analysis","volume":"24","author":"Li","year":"2024","journal-title":"BMC Endocr Disord"},{"issue":"1","key":"10.1016\/j.metop.2025.100385_bib149","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-025-98301-8","article-title":"Mechanism and role of H. pylori CagA-induced NLRP3 inflammasome in gastric cancer immune cell infiltration","volume":"15","author":"Wan","year":"2025","journal-title":"Sci Rep"},{"key":"10.1016\/j.metop.2025.100385_bib150","doi-asserted-by":"crossref","DOI":"10.1186\/1756-0500-5-284","article-title":"Prevalence of a marker of active Helicobacter pylori infection among patients with type 2 diabetes mellitus in Lagos, Nigeria","volume":"5","author":"Oluyemi","year":"2012","journal-title":"BMC Res Notes"},{"issue":"12","key":"10.1016\/j.metop.2025.100385_bib151","first-page":"892","article-title":"Helicobacter pylori seropositivity in patients with type 2 diabetes mellitus in south-east of Iran","volume":"51","author":"Jafarzadeh","year":"2013","journal-title":"Acta Med Iran"},{"issue":"9","key":"10.1016\/j.metop.2025.100385_bib152","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1111\/eci.12124","article-title":"Helicobacter pylori infection associated with high HbA1c and type 2 diabetes","volume":"43","author":"Hsieh","year":"2013","journal-title":"Eur J Clin Invest"},{"issue":"10","key":"10.1016\/j.metop.2025.100385_bib153","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1016\/j.numecd.2016.06.012","article-title":"Randomized, double-blind, placebo-controlled trial to evaluate the effect of Helicobacter pylori eradication on glucose homeostasis in type 2 diabetic patients","volume":"26","author":"Bonfigli","year":"2016","journal-title":"Nutr Metabol Cardiovasc Dis"},{"key":"10.1016\/j.metop.2025.100385_bib154","doi-asserted-by":"crossref","DOI":"10.1177\/2050312119832093","article-title":"Helicobacter pylori eradication in patients with type 2 diabetes mellitus: multicenter prospective observational study","volume":"7","author":"Nam","year":"2019","journal-title":"SAGE Open Med"},{"issue":"1","key":"10.1016\/j.metop.2025.100385_bib155","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-020-69208-3","article-title":"Helicobacter pylori infection, a risk factor for type 2 diabetes mellitus: a hospital-based cross-sectional study among dyspeptic patients in douala-cameroon","volume":"10","author":"Kouitcheu Mabeku","year":"2020","journal-title":"Sci Rep"},{"issue":"3","key":"10.1016\/j.metop.2025.100385_bib156","doi-asserted-by":"crossref","first-page":"179","DOI":"10.5603\/DK.2020.0012","article-title":"Evaluation of Helicobacter pylori IgG levels in type 2 diabetes mellitus patients","volume":"9","author":"Ghasemi","year":"2020","journal-title":"Clin Diabetol"},{"issue":"1","key":"10.1016\/j.metop.2025.100385_bib157","doi-asserted-by":"crossref","first-page":"8","DOI":"10.4103\/jfcm.JFCM_142_19","article-title":"Association between type 2 diabetes mellitus and Helicobacter pylori infection among Saudi patients attending national guard primary health care centers in the Western region, 2018","volume":"27","author":"Alzahrani","year":"2020","journal-title":"J Family Community Med"},{"issue":"3","key":"10.1016\/j.metop.2025.100385_bib158","doi-asserted-by":"crossref","first-page":"584","DOI":"10.3904\/kjim.2019.428","article-title":"Effect of Helicobacter pylori treatment on the long-term mortality in patients with type 2 diabetes","volume":"36","author":"Kim","year":"2021","journal-title":"Korean J Intern Med"},{"issue":"3","key":"10.1016\/j.metop.2025.100385_bib159","doi-asserted-by":"crossref","first-page":"579","DOI":"10.3904\/kjim.2021.194","article-title":"Long-term effect of the eradication of Helico-bacter pylori on the hemoglobin A1c in type 2 diabetes or prediabetes patients","volume":"37","author":"Kim","year":"2022","journal-title":"Kor J Intern Med"},{"issue":"1","key":"10.1016\/j.metop.2025.100385_bib160","doi-asserted-by":"crossref","first-page":"36","DOI":"10.5005\/jp-journals-10018-1310","article-title":"Helicobacter pylori infection and gastric microbiota","volume":"10","author":"Ozbey","year":"2020","journal-title":"Euroasian J Hepatogastroenterol"},{"key":"10.1016\/j.metop.2025.100385_bib161","article-title":"Gastric microbiota dysbiosis and Helicobacter pylori infection","volume":"14","author":"Zhang","year":"2023","journal-title":"Front Microbiol"},{"issue":"23","key":"10.1016\/j.metop.2025.100385_bib162","doi-asserted-by":"crossref","first-page":"2833","DOI":"10.1097\/CM9.0000000000003348","article-title":"Impacts of Helicobacter pylori infection and eradication on gastrointestinal microbiota: an up-to-date critical review and future perspectives","volume":"137","author":"Li","year":"2024","journal-title":"Chin Med J"},{"key":"10.1016\/j.metop.2025.100385_bib163","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.cophys.2021.04.003","article-title":"Interactions between H. pylori and the gastric microbiome: impact on gastric homeostasis and disease","volume":"21","author":"Serrano","year":"2021","journal-title":"Curr Opin Physiol"},{"key":"10.1016\/j.metop.2025.100385_bib164","doi-asserted-by":"crossref","DOI":"10.3389\/fcimb.2022.1105811","article-title":"Gastric microbiota in gastric cancer: different roles of Helicobacter pylori and other microbes","volume":"12","author":"Guo","year":"2023","journal-title":"Front Cell Infect Microbiol"}],"container-title":["Metabolism Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589936825000416?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589936825000416?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,12]],"date-time":"2025-09-12T05:45:45Z","timestamp":1757655945000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2589936825000416"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9]]},"references-count":164,"alternative-id":["S2589936825000416"],"URL":"https:\/\/doi.org\/10.1016\/j.metop.2025.100385","relation":{},"ISSN":["2589-9368"],"issn-type":[{"value":"2589-9368","type":"print"}],"subject":[],"published":{"date-parts":[[2025,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Helicobacter pylori infection and association with chronic diseases: A focus on cardiovascular disease, MASLD, and type 2 diabetes","name":"articletitle","label":"Article Title"},{"value":"Metabolism Open","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.metop.2025.100385","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"100385"}}